Sample Size for Multiple Hypothesis Testing in Biosimilar Development
Author:
Affiliation:
1. Novartis Pharma AG, Basel, Switzerland
2. Medical University of Vienna, Vienna, Austria
Funder
H2020 Marie Sklodowska-Curie Actions
Swiss State Secretariat for Education, Research and Innovation
Publisher
Informa UK Limited
Subject
Pharmaceutical Science,Statistics and Probability
Link
https://www.tandfonline.com/doi/pdf/10.1080/19466315.2017.1371071
Reference43 articles.
1. Sequential Tests of Hypotheses in Consecutive Trials
2. Multiple testing in clinical trials
3. Bioequivalence trials, intersection-union tests and equivalence confidence sets
4. Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine ( L antus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 study
5. Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sample size optimization for clinical trials using graphical approaches for multiplicity adjustment;Statistics in Medicine;2023-09-20
2. Strategic two-sample test via the two-armed bandit process;Journal of the Royal Statistical Society Series B: Statistical Methodology;2023-06-14
3. Biosimilar Drug Development;Principles and Practice of Clinical Trials;2022
4. Testing Procedures for Claiming Success on at Least k Out of m Hypotheses with an Application to Biosimilar Development;Statistics in Biopharmaceutical Research;2020-03-30
5. Biosimilar Drug Development;Principles and Practice of Clinical Trials;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3